Clinical Trial Update: Oral CXA-10 in Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial update for oral CXA-10 in pulmonary arterial hypertension; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• CXA-10

Snippet

Sponsor: Gladwin, Mark, MD | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2022-01-12